- Home
- ABOS vs MHLD Comparison
ABOS vs MHLD Comparison
Compare ABOS & MHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- MHLD
- Stock Information
- Founded
- ABOS 1996
- MHLD 2007
- Country
- ABOS United States
- MHLD Bermuda
- Employees
- ABOS N/A
- MHLD N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- MHLD Property-Casualty Insurers
- Sector
- ABOS Health Care
- MHLD Finance
- Exchange
- ABOS Nasdaq
- MHLD Nasdaq
- Market Cap
- ABOS 166.4M
- MHLD 177.6M
- IPO Year
- ABOS 2021
- MHLD 2008
- Fundamental
- Price
- ABOS $2.22
- MHLD $1.62
- Analyst Decision
- ABOS Strong Buy
- MHLD
- Analyst Count
- ABOS 4
- MHLD 0
- Target Price
- ABOS $9.00
- MHLD N/A
- AVG Volume (30 Days)
- ABOS 185.7K
- MHLD 54.2K
- Earning Date
- ABOS 08-13-2024
- MHLD 11-06-2024
- Dividend Yield
- ABOS N/A
- MHLD N/A
- EPS Growth
- ABOS N/A
- MHLD N/A
- EPS
- ABOS N/A
- MHLD N/A
- Revenue
- ABOS N/A
- MHLD $96,352,000.00
- Revenue This Year
- ABOS N/A
- MHLD N/A
- Revenue Next Year
- ABOS N/A
- MHLD N/A
- P/E Ratio
- ABOS N/A
- MHLD N/A
- Revenue Growth
- ABOS N/A
- MHLD 38.31
- 52 Week Low
- ABOS $1.81
- MHLD $1.19
- 52 Week High
- ABOS $5.76
- MHLD $2.55
- Technical
- Relative Strength Index (RSI)
- ABOS 32.70
- MHLD 38.21
- Support Level
- ABOS $2.73
- MHLD $1.63
- Resistance Level
- ABOS $2.92
- MHLD $1.77
- Average True Range (ATR)
- ABOS 0.19
- MHLD 0.11
- MACD
- ABOS -0.06
- MHLD -0.01
- Stochastic Oscillator
- ABOS 7.17
- MHLD 1.45
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About MHLD Maiden Holdings Ltd.
Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commercial package, commercial auto, and extended warranty. The Diversified Reinsurance segment provides small and midsize regional and specialty insurers with reinsurance capital products. Its revenues also include fee income earned from both its GLS business and IIS business as well as income generated from its investment portfolio.